Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer
Authors
Keywords
-
Journal
BMC CANCER
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-19
DOI
10.1186/s12885-020-07731-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Validation of miRNAs as Breast Cancer Biomarkers with a Machine Learning Approach
- (2019) Oneeb Rehman et al. Cancers
- miR-193: A new weapon against cancer
- (2019) Monireh Khordadmehr et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patients
- (2019) Thorsten Heilmann et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3
- (2018) Xiangdong Bai et al. BIOMEDICINE & PHARMACOTHERAPY
- miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study
- (2018) Weronika Świtlik et al. Cancer Biomarkers
- Adipose-derived stem cell-derived microvesicle-released miR-210 promoted proliferation, migration and invasion of endothelial cells by regulating RUNX3
- (2018) Zeqi Zheng et al. CELL CYCLE
- Euphol, a tetracyclic triterpene, from Euphorbia tirucalli induces autophagy and sensitizes temozolomide cytotoxicity on glioblastoma cells
- (2018) Viviane A. O. Silva et al. INVESTIGATIONAL NEW DRUGS
- Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage
- (2018) Hao Wang et al. Clinical Epigenetics
- Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway
- (2017) Dong Ren et al. Molecular Cancer
- mirDIP 4.1—integrative database of human microRNA target predictions
- (2017) Tomas Tokar et al. NUCLEIC ACIDS RESEARCH
- Downregulation of miR-193a-3p inhibits cell growth and migration in renal cell carcinoma by targeting PTEN
- (2017) Lingqi Liu et al. TUMOR BIOLOGY
- Candidate miRNAs in human breast cancer biomarkers: a systematic review
- (2017) Masoumeh Adhami et al. Breast Cancer
- Overexpression of mir-183 and mir-494 promotes proliferation and migration in human breast cancer cell lines
- (2017) Taciane Macedo et al. Oncology Letters
- MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1
- (2017) Julie-Ann Hulin et al. Scientific Reports
- Circulating miR-210 as a diagnostic and prognostic biomarker for colorectal cancer
- (2016) W. Wang et al. EUROPEAN JOURNAL OF CANCER CARE
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Lyndsay N. Harris et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA profiling in human breast cancer cell lines exposed to the anti-neoplastic drug cediranib
- (2016) A.L.R. Bordinhão et al. ONCOLOGY REPORTS
- Downregulation of microRNA-193-3p inhibits tumor proliferation migration and chemoresistance in human gastric cancer by regulating PTEN gene
- (2016) Bin Jian et al. TUMOR BIOLOGY
- Identification of a circulating microRNA signature to distinguish recurrence in breast cancer patients
- (2016) Dezheng Huo et al. Oncotarget
- Arm Selection Preference of MicroRNA-193a Varies in Breast Cancer
- (2016) Kuo-Wang Tsai et al. Scientific Reports
- Clinical implications of the intrinsic molecular subtypes of breast cancer
- (2015) Aleix Prat et al. BREAST
- Current State of Circulating MicroRNAs as Cancer Biomarkers
- (2015) Y. He et al. CLINICAL CHEMISTRY
- The Role of Hypoxia-Induced miR-210 in Cancer Progression
- (2015) Kyvan Dang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Orchestrating high-throughput genomic analysis with Bioconductor
- (2015) Wolfgang Huber et al. NATURE METHODS
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients
- (2015) Isabel Stückrath et al. Oncotarget
- A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients
- (2015) Shigeshi Ono et al. Oncotarget
- Epigenetically altered miR-193b targets cyclin D1 in prostate cancer
- (2015) Kirsi M. Kaukoniemi et al. Cancer Medicine
- Emerging roles of miR-210 and other non-coding RNAs in the hypoxic response
- (2014) X. Huang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study
- (2014) Augusto LF Marino et al. BMC CANCER
- Integrative analysis of the transcriptome profiles observed in type 1, type 2 and gestational diabetes mellitus reveals the role of inflammation
- (2014) Adriane F Evangelista et al. BMC Medical Genomics
- Circulating MicroRNA Biomarker Studies: Pitfalls and Potential Solutions
- (2014) K. W. Witwer CLINICAL CHEMISTRY
- miR-193a-3p Functions as a Tumor Suppressor in Lung Cancer by Down-regulating ERBB4
- (2014) Hongwei Liang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Elevated Expression of miR-210 Predicts Poor Survival of Cancer Patients: A Systematic Review and Meta-Analysis
- (2014) Jian Wang et al. PLoS One
- MicroRNAs in cancer: biomarkers, functions and therapy
- (2014) Josie Hayes et al. TRENDS IN MOLECULAR MEDICINE
- HypoxamiRs and Cancer: From Biology to Targeted Therapy
- (2013) Harriet E. Gee et al. ANTIOXIDANTS & REDOX SIGNALING
- Impact of DNA methyltransferases on the epigenetic regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in malignant melanoma
- (2013) Mario Venza et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells
- (2013) HARUO NAKANO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MicroRNA-143 is downregulated in breast cancer and regulates DNA methyltransferases 3A in breast cancer cells
- (2013) Enders K. O. Ng et al. TUMOR BIOLOGY
- High Expression of MicroRNA-210 is an Independent Factor Indicating a Poor Prognosis in Japanese Triple-negative Breast Cancer Patients
- (2012) T. Toyama et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Tumor suppressor function of RUNX3 in breast cancer
- (2012) Lin-Feng Chen JOURNAL OF CELLULAR BIOCHEMISTRY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Impedance measurement: A new method to detect ligand-biased receptor signaling
- (2011) M. Kammermann et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer
- (2011) Jelena Radojicic et al. CELL CYCLE
- Gene expression profiling in breast cancer: classification, prognostication, and prediction
- (2011) Jorge S Reis-Filho et al. LANCET
- MicroRNA-193b Represses Cell Proliferation and Regulates Cyclin D1 in Melanoma
- (2010) Jiamin Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- Deconstructing the molecular portraits of breast cancer
- (2010) Aleix Prat et al. Molecular Oncology
- MicroRNAs in Cancer
- (2009) Ramiro Garzon et al. Annual Review of Medicine
- Origins and Mechanisms of miRNAs and siRNAs
- (2009) Richard W. Carthew et al. CELL
- Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines
- (2009) S-K Leivonen et al. ONCOGENE
- MCF-7 breast carcinoma cells do not express caspase-3
- (2008) Reiner U. Jänicke BREAST CANCER RESEARCH AND TREATMENT
- Expression of RUNX3 Gene, Methylation Status and Clinicopathological Significance in Breast Cancer and Breast Cancer Cell Lines
- (2008) Ying Jiang et al. PATHOBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More